| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.069 | 0.2 |